Biotechnology in the United States of America (USA) - Market Summary, Competitive Analysis and Forecast to 2025
Biotechnology in the United States of America (USA) - Market Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The US biotechnology market had total revenues of $208.2bn in 2020, representing a compound annual growth rate (CAGR) of 6% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $122.6bn, equivalent to 58.9% of the market's overall value.
- There is a wide range of funding available for biotech firms in the US, such as the Small Business Innovation Research (SBIR) program and Small Business Technology Transfer (STTR) program, which has supported growth in the market and attracted new entrants.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts
- What was the size of the United States biotechnology market by value in 2020?
- What will be the size of the United States biotechnology market in 2025?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the United State's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Do leading players have any notable weaknesses?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Do leading players have any notable weaknesses?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: United States biotechnology industry value: $ billion, 2016-20
Table 2: United States biotechnology industry category segmentation: $ billion, 2020
Table 3: United States biotechnology industry geography segmentation: $ billion, 2020
Table 4: United States biotechnology industry value forecast: $ billion, 2020-25
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: AbbVie Inc.: key facts
Table 10: AbbVie Inc.: Annual Financial Ratios
Table 11: AbbVie Inc.: Annual Financial Ratios (Continued)
Table 12: AbbVie Inc.: Key Employees
Table 13: Amgen, Inc.: key facts
Table 14: Amgen, Inc.: Annual Financial Ratios
Table 15: Amgen, Inc.: Key Employees
Table 16: Amgen, Inc.: Key Employees Continued
Table 17: Biogen, Inc.: key facts
Table 18: Biogen, Inc.: Annual Financial Ratios
Table 19: Biogen, Inc.: Key Employees
Table 20: United States size of population (million), 2016-20
Table 21: United States gdp (constant 2005 prices, $ billion), 2016-20
Table 22: United States gdp (current prices, $ billion), 2016-20
Table 23: United States inflation, 2016-20
Table 24: United States consumer price index (absolute), 2016-20
Table 25: United States exchange rate, 2016-20
Table 1: United States biotechnology industry value: $ billion, 2016-20
Table 2: United States biotechnology industry category segmentation: $ billion, 2020
Table 3: United States biotechnology industry geography segmentation: $ billion, 2020
Table 4: United States biotechnology industry value forecast: $ billion, 2020-25
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: AbbVie Inc.: key facts
Table 10: AbbVie Inc.: Annual Financial Ratios
Table 11: AbbVie Inc.: Annual Financial Ratios (Continued)
Table 12: AbbVie Inc.: Key Employees
Table 13: Amgen, Inc.: key facts
Table 14: Amgen, Inc.: Annual Financial Ratios
Table 15: Amgen, Inc.: Key Employees
Table 16: Amgen, Inc.: Key Employees Continued
Table 17: Biogen, Inc.: key facts
Table 18: Biogen, Inc.: Annual Financial Ratios
Table 19: Biogen, Inc.: Key Employees
Table 20: United States size of population (million), 2016-20
Table 21: United States gdp (constant 2005 prices, $ billion), 2016-20
Table 22: United States gdp (current prices, $ billion), 2016-20
Table 23: United States inflation, 2016-20
Table 24: United States consumer price index (absolute), 2016-20
Table 25: United States exchange rate, 2016-20
LIST OF FIGURES
Figure 1: United States biotechnology industry value: $ billion, 2016-20
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2020
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: United States biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2020
Figure 1: United States biotechnology industry value: $ billion, 2016-20
Figure 2: United States biotechnology industry category segmentation: % share, by value, 2020
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: United States biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2020
